Siebert John M Insider Trades

Insider Trading History

Track insider trading activity for Siebert John M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$113k 3,886 shares
$29.06
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $3.87M 87,943 shares
Last Trade
Feb 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 3,886 shares
$29.06
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $363k 8,252 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 8,252 shares
$27.94
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $277k 6,293 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$243k 6,293 shares
$38.60
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 22, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$150k 3,882 shares
$38.57
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $3.7M 84,057 shares
Last Trade
Feb 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 3,882 shares
$38.57
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $302k 6,847 shares
Last Trade
Feb 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 6,847 shares
$32.20
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 19, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$139k 4,222 shares
$32.90
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $3.53M 80,175 shares
Last Trade
Feb 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 4,222 shares
$32.90
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $3.34M 75,953 shares
Last Trade
Aug 11, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$368k 15,000 shares
$24.53
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$368k 15,000 shares
$24.53
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $324k 7,365 shares
Last Trade
Feb 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 7,365 shares
$29.61
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $410k 9,305 shares
Last Trade
Feb 21, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$223k 9,305 shares
$23.99
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $2.68M 60,953 shares
Last Trade
Feb 21, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 5,211 shares
$23.99
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Jun 20, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$311k 10,000 shares
$31.08
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $2.45M 55,742 shares
Last Trade
Jun 20, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$311k 10,000 shares
$31.08
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $2.01M 45,742 shares
Last Trade
Apr 25, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$366k 10,000 shares
$36.55
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $440k 10,000 shares
Last Trade
Apr 25, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$366k 10,000 shares
$36.55
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $547k 12,427 shares
Last Trade
Feb 22, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$457k 12,427 shares
$36.75
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $547k 12,427 shares
Last Trade
Feb 22, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$457k 12,427 shares
$36.75
$44.04

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up